My onc mentioned this last week. I know it’s all about the timingand it won’t be for me. Not much info here but interesting they are looking for half the patients to have failed IPI. I do get frustrated with the entire clinical trials exclusion process but at least some can be helped. If I were a candidate, I’d start making phone calls!
My onc mentioned this last week. I know it’s all about the timingand it won’t be for me. Not much info here but interesting they are looking for half the patients to have failed IPI. I do get frustrated with the entire clinical trials exclusion process but at least some can be helped. If I were a candidate, I’d start making phone calls!
The bio marker is PDL1…they are thinking that if the melanoma doesn't have it- the anti pd-1 will not work-period…knowing if this is true or notwill save many people precious time instead of doing treatment that will not work, Around 110 people from Moffittin the BMS trial have been signing releases so our melanoma can be tested to see if in fact we have the PDL1.BMS is doing the testing. Currently they are not excluding anyone from the trial that does not have the PDL1.
The bio marker is PDL1…they are thinking that if the melanoma doesn't have it- the anti pd-1 will not work-period…knowing if this is true or notwill save many people precious time instead of doing treatment that will not work, Around 110 people from Moffittin the BMS trial have been signing releases so our melanoma can be tested to see if in fact we have the PDL1.BMS is doing the testing. Currently they are not excluding anyone from the trial that does not have the PDL1.
PS with melanoma if IPI ( Yervoy) has a 50% failure, it also means it has a 50% success rate…which is awesome news! I would doubt it has that high of success…perhaps PR's however.
PS with melanoma if IPI ( Yervoy) has a 50% failure, it also means it has a 50% success rate…which is awesome news! I would doubt it has that high of success…perhaps PR's however.
My understanding is that half (50%) of the people they are taking must have already failed IPI. I think they’ve always been excluded before from Anti pd1 and Anti pdl1. So for some lucky 40 people, this is big news.
My understanding is that half (50%) of the people they are taking must have already failed IPI. I think they’ve always been excluded before from Anti pd1 and Anti pdl1. So for some lucky 40 people, this is big news.
My understanding is that half (50%) of the people they are taking must have already failed IPI. I think they’ve always been excluded before from Anti pd1 and Anti pdl1. So for some lucky 40 people, this is big news.
PS with melanoma if IPI ( Yervoy) has a 50% failure, it also means it has a 50% success rate…which is awesome news! I would doubt it has that high of success…perhaps PR's however.
The bio marker is PDL1…they are thinking that if the melanoma doesn't have it- the anti pd-1 will not work-period…knowing if this is true or notwill save many people precious time instead of doing treatment that will not work, Around 110 people from Moffittin the BMS trial have been signing releases so our melanoma can be tested to see if in fact we have the PDL1.BMS is doing the testing. Currently they are not excluding anyone from the trial that does not have the PDL1.
Viewing 2 reply threads
You must be logged in to reply to this topic.
About the MRF Patient Forum
The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.
The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.
.
.
